{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:36:40Z","timestamp":1788367000516,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81703456"],"award-info":[{"award-number":["81703456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973271"],"award-info":[{"award-number":["81973271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03179-3","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:13:16Z","timestamp":1740219196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle"],"prefix":"10.1186","volume":"23","author":[{"given":"Dezhi","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"3179_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41577-019-0141-8","volume":"19","author":"GN Lai","year":"2019","unstructured":"Lai GN, Ostuni R, Hidalgo A. Heterogeneity of neutrophils. Nat Rev Immunol. 2019;19:255\u201365.","journal-title":"Nat Rev Immunol"},{"key":"3179_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21:938\u201345.","journal-title":"Nat Med"},{"key":"3179_CR3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1164\/rccm.202004-1116TR","volume":"202","author":"A Mirouse","year":"2020","unstructured":"Mirouse A, et al. Sepsis and cancer: an interplay of friends and foes. Am J Respir Crit Care Med. 2020;202:1625\u201335.","journal-title":"Am J Respir Crit Care Med"},{"key":"3179_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22:173\u201387.","journal-title":"Nat Rev Immunol"},{"key":"3179_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jconrel.2023.02.007","volume":"355","author":"M Raith","year":"2023","unstructured":"Raith M, et al. Obesity and inflammation influence pharmacokinetic profiles of PEG-based nanoparticles. J Control Release. 2023;355:434\u201345.","journal-title":"J Control Release"},{"key":"3179_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576\u201390.","journal-title":"Nat Rev Endocrinol"},{"key":"3179_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.apsb.2022.06.005","volume":"13","author":"D Sui","year":"2023","unstructured":"Sui D, et al. Sialic acid-mediated photochemotherapy enhances infiltration of CD8+ T cells from tumor-draining lymph nodes into tumors of immunosenescent mice. Acta Pharm Sin B. 2023;13:425\u201339.","journal-title":"Acta Pharm Sin B"},{"key":"3179_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41423-023-01058-1","volume":"20","author":"J Qu","year":"2023","unstructured":"Qu J, et al. Neutrophil diversity and plasticity: implications for organ transplantation. Cell Mol Immunol. 2023;20:993\u20131001.","journal-title":"Cell Mol Immunol"},{"key":"3179_CR9","doi-asserted-by":"publisher","first-page":"eadf6493","DOI":"10.1126\/science.adf6493","volume":"383","author":"MSF Ng","year":"2024","unstructured":"Ng MSF, et al. Deterministic reprogramming of neutrophils within tumors. Science. 2024;383:eadf6493.","journal-title":"Science."},{"key":"3179_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.immuni.2018.02.002","volume":"48","author":"M Evrard","year":"2018","unstructured":"Evrard M, et al. Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions. Immunity. 2018;48:364-379.e8.","journal-title":"Immunity"},{"key":"3179_CR11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201803","volume":"218","author":"F Veglia","year":"2021","unstructured":"Veglia F, et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J Exp Med. 2021;218: e20201803.","journal-title":"J Exp Med"},{"key":"3179_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41565-023-01374-7","volume":"18","author":"Z Luo","year":"2023","unstructured":"Luo Z, et al. Neutrophil hitchhiking for drug delivery to the bone marrow. Nat Nanotechnol. 2023;18:647\u201356.","journal-title":"Nat Nanotechnol"},{"key":"3179_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.aam9690","volume":"358","author":"J Wang","year":"2017","unstructured":"Wang J, et al. Visualizing the function and fate of neutrophils in sterile injury and repair. Science. 2017;358:111\u20136.","journal-title":"Science"},{"key":"3179_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101454","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Nanoparticulation of prodrug into medicines for cancer therapy. Adv Sci. 2021;8: e2101454.","journal-title":"Adv Sci"},{"key":"3179_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.addr.2020.07.027","volume":"154\u2013155","author":"A Gabizon","year":"2020","unstructured":"Gabizon A, et al. Development of Promitil\u00ae, a lipidic prodrug of mitomycin C in PEGylated liposomes: from bench to bedside. Adv Drug Deliv Rev. 2020;154\u2013155:13\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"3179_CR16","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1021\/acsnano.8b04947","volume":"12","author":"H Zhou","year":"2018","unstructured":"Zhou H, et al. Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation. ACS Nano. 2018;12:10130\u201341.","journal-title":"ACS Nano"},{"key":"3179_CR17","doi-asserted-by":"publisher","first-page":"32110","DOI":"10.1021\/acsami.3c02762","volume":"15","author":"D Sui","year":"2023","unstructured":"Sui D, et al. Cleavable-branched polymer-modified liposomes reduce accelerated blood clearance and enhance photothermal therapy. ACS Appl Mater Interfaces. 2023;15:32110\u201320.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3179_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102110","volume":"37","author":"D Sui","year":"2024","unstructured":"Sui D, et al. Transformable binary-prodrug nanoparticles harness heterogeneity of neutrophils to overcome multidrug resistance and promote pyroptosis in cancer. Appl Mater Today. 2024;37: 102110.","journal-title":"Appl Mater Today"},{"key":"3179_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121081","volume":"310","author":"D Sui","year":"2022","unstructured":"Sui D, et al. Optimization design of sialic acid derivatives enhances the performance of liposomes for modulating immunosuppressive tumor microenvironments. Life Sci. 2022;310: 121081.","journal-title":"Life Sci"},{"key":"3179_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120552","volume":"602","author":"D Sui","year":"2021","unstructured":"Sui D, et al. Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity. Int J Pharm. 2021;602: 120552.","journal-title":"Int J Pharm"},{"key":"3179_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1080\/17425247.2020.1813714","volume":"17","author":"Y Haggag","year":"2020","unstructured":"Haggag Y, et al. Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells. Expert Opin Drug Deliv. 2020;17:1655\u201369.","journal-title":"Expert Opin Drug Deliv"},{"key":"3179_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijpharm.2017.02.006","volume":"521","author":"YA Haggag","year":"2017","unstructured":"Haggag YA, et al. Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. Int J Pharm. 2017;521:40\u201353.","journal-title":"Int J Pharm"},{"key":"3179_CR23","doi-asserted-by":"publisher","first-page":"bbad419","DOI":"10.1093\/bib\/bbad419","volume":"25","author":"J Dong","year":"2023","unstructured":"Dong J, Wu Z, Xu H. FormulationAI: a novel web-based platform for drug formulation design driven by artificial intelligence. Brief Bioinform. 2023;25:bbad419.","journal-title":"Brief Bioinform."},{"key":"3179_CR24","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1021\/acs.molpharmaceut.6b00865","volume":"14","author":"X Wei","year":"2017","unstructured":"Wei X, et al. Characterization of pegylated liposomal mitomycin C lipid-based prodrug (promitil) by high sensitivity differential scanning calorimetry and cryogenic transmission electron microscopy. Mol Pharm. 2017;14:4339\u201345.","journal-title":"Mol Pharm"},{"key":"3179_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","volume":"18","author":"J Hou","year":"2021","unstructured":"Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin Oncol. 2021;18:261\u201379.","journal-title":"Nat Rev Clin Oncol"},{"key":"3179_CR26","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cell.2023.03.005","volume":"186","author":"A Ager","year":"2023","unstructured":"Ager A. Cancer immunotherapy: T cells and neutrophils working together to attack cancers. Cell. 2023;186:1304\u20136.","journal-title":"Cell"},{"key":"3179_CR27","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui C, et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021;184:3163-3177.e21.","journal-title":"Cell"},{"key":"3179_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","volume":"187","author":"Y Wu","year":"2024","unstructured":"Wu Y, et al. Neutrophil profiling illuminates anti-tumor antigen-presenting potency. Cell. 2024;187:1422-1439.e24.","journal-title":"Cell"},{"key":"3179_CR29","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity. 2023;56:2188\u2013205.","journal-title":"Immunity"},{"key":"3179_CR30","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1182\/blood.2023023444","volume":"143","author":"A Moffat","year":"2024","unstructured":"Moffat A, Gwyer Findlay E. Evidence for antigen presentation by human neutrophils. Blood. 2024;143:2455\u201363.","journal-title":"Blood"},{"key":"3179_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"3179_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18:121\u20136.","journal-title":"Ann Afr Med"},{"key":"3179_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41586-022-04536-0","volume":"604","author":"SP Bapat","year":"2022","unstructured":"Bapat SP, et al. Obesity alters pathology and treatment response in inflammatory disease. Nature. 2022;604:337\u201342.","journal-title":"Nature"},{"key":"3179_CR34","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.7150\/thno.56157","volume":"11","author":"Y Tong","year":"2021","unstructured":"Tong Y, et al. High fat diet, gut microbiome and gastrointestinal cancer. Theranostics. 2021;11:5889\u2013910.","journal-title":"Theranostics"},{"key":"3179_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041197","volume":"14","author":"A Singh","year":"2024","unstructured":"Singh A, et al. Aging and inflammation. Cold Spring Harb Perspect Med. 2024;14: a041197.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3179_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41590-024-01828-7","volume":"25","author":"ACY Chen","year":"2024","unstructured":"Chen ACY, et al. The aged tumor microenvironment limits T cell control of cancer. Nat Immunol. 2024;25:1033\u201345.","journal-title":"Nat Immunol"},{"key":"3179_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13054-021-03481-0","volume":"25","author":"X Qi","year":"2021","unstructured":"Qi X, et al. Identification and characterization of neutrophil heterogeneity in sepsis. Crit Care. 2021;25:50.","journal-title":"Crit Care"},{"key":"3179_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164585","volume":"133","author":"H Jin","year":"2023","unstructured":"Jin H, et al. Antigen-presenting aged neutrophils induce CD4+ T cells to exacerbate inflammation in sepsis. J Clin Invest. 2023;133: e164585.","journal-title":"J Clin Invest"},{"key":"3179_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612:141\u20137.","journal-title":"Nature"},{"key":"3179_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934444","volume":"13","author":"Z Cao","year":"2022","unstructured":"Cao Z, et al. Roles of mitochondria in neutrophils. Front Immunol. 2022;13: 934444.","journal-title":"Front Immunol"},{"key":"3179_CR41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ijc.11615","volume":"20","author":"D Peer","year":"2004","unstructured":"Peer D, Margalit R. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer. 2004;20:780\u20139.","journal-title":"Int J Cancer"},{"key":"3179_CR42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11095-015-1819-7","volume":"33","author":"Y Amitay","year":"2016","unstructured":"Amitay Y, et al. Pharmacologic studies of a prodrug of mitomycin C in pegylated liposomes (Promitil\u00ae): high stability in plasma and rapid thiolytic prodrug activation in tissues. Pharm Res. 2016;33:686\u2013700.","journal-title":"Pharm Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03179-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:13:19Z","timestamp":1740219199000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03179-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3179"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03179-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were executed according to the protocols approved by the Shenyang Pharmaceutical University Animal Care and Use Committee (SYXK2022-0009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}